Prognostic value of [18F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumors
Preoperative [<sup>18</sup>F]FET-PET can provide prognostic information in distinct subgroups of diffuse low-grade gliomas not having undergone adjuvant therapies. Following external validation, preoperative [<sup>18</sup>F]FET-PET may possibly be employed as a decision-support tool to inform the choice of adjuvant therapies in astrocytoma.
Authors
- Michael Schäfers (ORCID: https://orcid.org/0000-0002-4008-2755)
- Wolfgang Roll (ORCID: https://orcid.org/0000-0002-3746-9393)
- Matthias Weckesser
- Philipp Backhaus (ORCID: https://orcid.org/0000-0003-4164-4104)
- Oliver Grauer
- Philipp Schindler (ORCID: https://orcid.org/0000-0002-8098-9853)
- Walter Stummer (ORCID: https://orcid.org/0000-0002-3460-0640)
- Lorenz König
- Michael Müther
Institutions
- University of Münster (DE)
- University Hospital Münster (DE)
- West Cancer Center (US)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2025-09-10
- DOI
- https://doi.org/10.1007/s00259-025-07543-1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Westfälische Wilhelms-Universität Münster